BiotechTube

Norgestimate/Ehinyl Estradiol; Folic acid.

Phase 1Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Female Contraception

Conditions

Female Contraception, Contraception, Therapeutic Equivalency, Pharmacokinetics

Trial Timeline

May 1, 2005 → Aug 1, 2005

NCT ID
NCT00709189

About Norgestimate/Ehinyl Estradiol; Folic acid.

Norgestimate/Ehinyl Estradiol; Folic acid. is a phase 1 stage product being developed by Johnson & Johnson for Female Contraception. The current trial status is completed. This product is registered under clinical trial identifier NCT00709189. Target conditions include Female Contraception, Contraception, Therapeutic Equivalency.

What happened to similar drugs?

2 of 15 similar drugs in Female Contraception were approved

Approved (2) Terminated (0) Active (13)
🔄Gemcitabine + liposomal doxorubicinEli LillyPhase 3
✅Eribulin Injection [Halaven] + Paclitaxel injectionEisaiApproved
🔄Gemcitabine + Paclitaxel + CarboplatinEli LillyPhase 3
🔄Abemaciclib 50 MG; 150mg 1-0-1 per osEli LillyPhase 3
🔄SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
🔄SHR7280；Ganirelix Acetate Injection simulant + SHR7280 simulant； Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
🔄Fulvestrant 500mg + Palbociclib 125mg + Goserelin 3.6 MG + PlacebosAstraZenecaPhase 3

Hype Score Breakdown

Clinical
6
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT00709189Phase 1Completed

Competing Products

20 competing products in Female Contraception

See all competitors
ProductCompanyStageHype Score
FulvestrantDr. Reddy's LaboratoriesPre-clinical
19
Fulvestrant + AbemaciclibEli LillyPhase 2
39
Gemcitabine + liposomal doxorubicinEli LillyPhase 3
40
ASP3325 + PlaceboAstellas PharmaPhase 1
29
EnsitrelvirShionogiPhase 1
29
Eribulin Injection [Halaven] + Paclitaxel injectionEisaiApproved
39
Gemcitabine + Paclitaxel + CarboplatinEli LillyPhase 3
40
Abemaciclib 50 MG; 150mg 1-0-1 per osEli LillyPhase 3
44
Abemaciclib, durvalumab and aromatase inhibitorEli LillyPhase 1
21
norelgestromin/ethinyl estradiol (NGMN/EE) transdermal contraceptive system.Johnson & JohnsonPhase 1
29
SHR6390 + placeboJiangsu Hengrui MedicinePhase 3
44
SHR7280 tabletsJiangsu Hengrui MedicinePhase 2
35
SHR7280；Ganirelix Acetate Injection simulant + SHR7280 simulant； Ganirelix Acetate InjectionJiangsu Hengrui MedicinePhase 3
40
SHR3162Jiangsu Hengrui MedicinePhase 1
25
AZD3293 + PlaceboAstraZenecaPhase 1
29
Fulvestrant 500mg + Palbociclib 125mg + Goserelin 3.6 MG + PlacebosAstraZenecaPhase 3
40
AZD2516 + PlaceboAstraZenecaPhase 1
29
Durvalumab + TremelimumabAstraZenecaPhase 2
39
Dapagliflozin + Metformin + Dapagliflozin + MetforminAstraZenecaPhase 1
29
AZD4901 (oral) + Placebo to match AZD4901AstraZenecaPhase 2
35